Transfusion of Blood Products is not Associated with Intensive Care Unit-Acquired Weakness when Corrected for Illness Severity

Abstract

Introduction Intensive Care Unit-acquired weakness (ICU-AW) is a common and severe complication of intensive care admission. We studied the effect of blood product transfusion (possibly a modifiable risk factor) on ICU-AW. Methods Records of blood product transfusion (red blood cell, platelet and plasma) were analyzed in a database from a prospective observational cohort study where newly admitted ICU patients who were mechanically ventilated ≥2 days were included. Manual muscle strength was measured according to the Medical Research Council (MRC) scale, when patients were awake and attentive. ICU–AW was defined as an average MRC score <4. Results Of 196 patients, 98 patients (50%) were diagnosed with ICU-AW. A significantly higher odds ratio (OR) for ICU-AW was found in patients receiving red blood cells(OR 2.85, 95% CI 1.58-5.15), plasma (OR 2.38, 95% CI 1.30–4.35) or platelet transfusion (OR 2.09, 95% CI 1.16–3.75) compared to non-transfused patients. The number of red blood cell units (OR 1.07, 95% CI 1.02-1.13) and platelet units (OR 1.24, 95% CI 1.07-1.43) were also associated with ICU-AW. However, when corrected for illness severity, these associations were no longer significant. Conclusion The association between transfusion and ICU-AW is explained by illness severity. Risk reducing strategies to prevent development of ICU-AW should focus on other possible risk factors.

Authors and Affiliations

Woodward Roger, Wieske Luuk, Juffermans Nicole, Horn Janneke

Keywords

Related Articles

Perioperative Fetal Monitoring during Acute Heart Valve Surgery in the 16th Week of Pregnancy: A Case Study with Follow up after Five Years

Cardiac surgery during pregnancy carries an extremely high fetal risk. When conducting anesthesia in the gravid patient care must be taken to avoid uterine contractions, and fetal hypoxia. Thus, in such cases, monitoring...

Comparative Study between Levobupivacine versus Levobupivacaine Plus Dexmedetomidine for Transversus Abdominis Plane Block ?TAP? in Post-Operative Pain Management after Abdominoplasty

Aim of the work Transversus abdominis plane “TAP’’ block has been reported to be effective for post-operative analgesia for patients undergoing surgery involving abdominal wall incision by blocking anterior branches of t...

Asymptomatic Pheochromocytoma Interpreted as Non-Functioning Incidentaloma: A Major Challenge: Case Report and Review

Introduction Adrenal incidentaloma (AI) is a result of easy availability of imagiological diagnostic techniques and may include many primary, metastatic, benign, and malignant entities, the majority of which are benign...

Transfusion of Blood Products is not Associated with Intensive Care Unit-Acquired Weakness when Corrected for Illness Severity

Introduction Intensive Care Unit-acquired weakness (ICU-AW) is a common and severe complication of intensive care admission. We studied the effect of blood product transfusion (possibly a modifiable risk factor) on ICU-A...

Anesthetic Considerations in Patient with Wolff-Parkinson-White Syndrome for Laparoscopic Cholecystectomy: Role of Perioperative Dexmedetomidine

Wolff-Parkinson-White (WPW) syndrome is a cardiac disorder having abnormal electrical communication between atria and ventricles. It is an uncommon disorder may be asymptomatic or present with symptoms like palpitation....

Download PDF file
  • EP ID EP618925
  • DOI -
  • Views 133
  • Downloads 0

How To Cite

Woodward Roger, Wieske Luuk, Juffermans Nicole, Horn Janneke (2015). Transfusion of Blood Products is not Associated with Intensive Care Unit-Acquired Weakness when Corrected for Illness Severity. Enliven: Journal of Anesthesiology and Critical Care Medicine, 2(8), 106-109. https://europub.co.uk/articles/-A-618925